Jessica Rigal Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 30 Harbour Isle Dr W Unit 202, Hutchinson Island, FL 34949 Phone: 917-710-1057 |
News Archive
A new blood test developed by scientists and clinicians is able to detect the presence of prostate cancer and confirm how advanced it is.
ARIAD Pharmaceuticals, Inc. today announced that its investigational pan-BCR-ABL inhibitor, AP24534, has been granted orphan drug designation by both the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In the U.S., the orphan designation of AP24534 is for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and in the E.U., its orphan designation is for CML and acute lymphoblastic leukemia.
Researchers in Portugal have discovered that a specific mutation of the COX2 gene seems to play a role in the onset of ovarian cancer, increasing women's susceptibility to developing the disease.
Though Indonesia is "widely seen as a development success story - indeed, it is sometimes referred to as one of Asia's 'rising powers' ... in the area of maternal health, the successes have been modest and much remains to be done," Andrew Rosser, associate director of the Indo-Pacific Governance Research Centre at the University of Adelaide, writes in an Inside Indonesia opinion piece.
Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center will serve as one of the lead institutions for a new multi-center clinical trial of anti-VISTA, now open and recruiting for patient enrollment.
› Verified 1 days ago